Literature DB >> 20491521

Application of Dolichos biflorus in immunoassay detection of kidney collecting duct biomarkers.

Samer Sourial1, Lydia Searchfield, Ina Schuppe-Koistinen, Graham R Betton, Daniela Riccardi, Sally A Price.   

Abstract

Currently there are no biomarkers for detecting collecting duct damage in man. Antibodies to several collecting duct-specific antigens exist but sandwich assays have been difficult to establish due to the need for two different antibodies to the same protein. We hypothesized that a collecting duct-specific lectin could be used in combination with a collecting duct-specific antibody to negate the need for two different antibodies. The collecting duct specificity of selected antibodies (NiCa II 13C2, Pap XI 3C7, HuPaP VII 2B11 and aquaporin 2), was verified by immunohistochemistry. Aquaporin 2 and Pap XI 3C7 were used successfully in setting up assays with the lectin Dolichos biflorus, using the Meso Scale Discovery (MSD) platform. Antigen expression was highest in the papillae of rat and human kidney (corresponding to the greatest density of collecting ducts) and was also present in normal urine. We propose that further qualification and validation would lead to an assay for detecting collecting duct damage in man.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20491521     DOI: 10.3109/1354750X.2010.483526

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  2 in total

1.  Fulvene-5 inhibition of Nadph oxidases attenuates activation of epithelial sodium channels in A6 distal nephron cells.

Authors:  David Trac; Bingchen Liu; Alan C Pao; Sheela V Thomas; Michael Park; Charles A Downs; He-Ping Ma; My N Helms
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

2.  Phosphorylcholine esterase is critical for Dolichos biflorus and Helix pomatia agglutinin binding to pneumococcal teichoic acid.

Authors:  Meng-Lan Zhou; Michael R Frost; Ying-Chun Xu; Moon H Nahm
Journal:  J Basic Microbiol       Date:  2020-08-27       Impact factor: 2.281

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.